Mogamulizumab Superior to Vorinostat in Cutaneous T Cell Lymphoma

Results were recently presented at the 59th American Society of Hematology ASH Annual Meeting and Exposition in Atlanta from a international comparative clinical trail evaluating mogamulizumab in patients with previously treated cutaneous T-cell lymphoma [...]